Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of New Subcutaneous Glucose Sensor With Recording Devices - Phase 3 Group

NCT04020822 is registered in ClinicalTrials.gov with Medtronic MiniMed, Inc. as lead sponsor.

NCT NCT04020822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04020822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of New Subcutaneous Glucose Sensor With Recording Devices - Phase 3 Group
Lead sponsor
Medtronic MiniMed, Inc.
Phase
Not applicable
Overall status
Completed
Start date
July 29, 2019
Completion date
August 27, 2019
Enrollment
19 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes, type 2 diabetes